An Evaluation of 12-months in Phase IV Cardiac Rehabilitation by Meadows, Steve
Kent Academic Repository
Full text document (pdf)
Copyright & reuse
Content in the Kent Academic Repository is made available for research purposes. Unless otherwise stated all
content is protected by copyright and in the absence of an open licence (eg Creative Commons), permissions 
for further reuse of content should be sought from the publisher, author or other copyright holder. 
Versions of research
The version in the Kent Academic Repository may differ from the final published version. 
Users are advised to check http://kar.kent.ac.uk for the status of the paper. Users should always cite the 
published version of record.
Enquiries
For any further enquiries regarding the licence status of this document, please contact: 
researchsupport@kent.ac.uk
If you believe this document infringes copyright then please contact the KAR admin team with the take-down 
information provided at http://kar.kent.ac.uk/contact.html
Citation for published version
Meadows, Steve  (2019) An Evaluation of 12-months in Phase IV Cardiac Rehabilitation.    In:
BACPR Exercise Professionals Spring Group Study Day, 17 May 2019, Birmingham, UK.   
 (Unpublished)
DOI




AN EVALUATION OF 12-MONTHS IN PHASE IV CARDIAC REHABILITATION
School of Sport and Exercise Sciences, University of Kent, The Medway Building, Chatham Maritime, Kent. ME4 4AG
S. MEADOWS & J. JAH
CORRESPONDENCE: s.meadows@kent.ac.uk
Introduction
Exercise-based cardiac rehabilitation (CR) is a fundamental part of
recovery from heart-related issues and also an important
secondary prevention strategy for risk factor management.
Study Aims 
To evaluate key health & fitness parameters of cardiac patients




25 cardiac patients referred to a community Phase IV CR circuit
class (males = 16; females = 9; mean age 74.1 ± 5.9 years) were
evaluated for key health and functional capacity parameters over
a 12-month period (2018 & 2019).
Measurements
Anthropometric: body mass index (BMI) & waist circumference
(WC); health: resting systolic (SBP), diastolic blood pressure (DBP)
& resting heart rate (RHR); and functional capacity measurement:
6-minute shuttle walking distance (6MWD).
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Results (mean ± SD)
BMI, WC, SBP, DBP & RHR did not significantly change. BMI was
reported in an overweight classification (26.41 ± 2.98 kg/m2). 40%
of participants had a WC that exceeded recommended levels for
substantially increased health risk (females ≥ 88 cm; males ≥ 102
cm). SBP and DBP both decreased and remained in a
normotensive range. However, 6MWD significantly increased from
492.16 ± 79.97 m to 509.20 ± 90.85 m (p=0.037).
Conclusion
A once a week circuit-based exercise training session did improve
functional capacity of Phase IV participants, indicating increased
fitness. However, it did not positively impact on anthropometric
parameters (BMI, WC). Additional interventions are needed at Phase
IV to effectively manage all risk factors to preserve health.
Limitations
Due to resource limitations it was not possible to track individual
physical activity or attendance data. 6MWT did not provide a peak
value, although participants were instructed to walk as far as possible
in 6-minutes.
Further Research Recommendations
Supervised CR exercise can help patients regain & sustain their health,
independence & quality of life. It also provides an effective secondary
prevention strategy, helping to reduce future costs & burden to carers
& the healthcare system. Continued engagement with Phase IV
exercise provides an opportunity for further improvement in health &
functional status as part of CVD risk management. This work provides
a compelling case for longitudinal studies tracking CVD patients to
ensure behaviours & education messages promoted early in the CR
journey are reinforced & patients receive regular evaluation on key
metrics for CVD reduction.
Phase IV CR Exercise Intervention (1 x week)
Warm Up (15 minutes)
Graded cardiovascular (CV) warm-up, consisting of various multi-
directional mobility movements, co-ordination & dynamic
stretching exercises.
CV Conditioning Component (40 minutes)
Circuit format of alternating CV & muscular strength endurance
(MSE) exercises (using resistance bands or light hand weights),
e.g. shuttle walking, standing press-ups, sit to stand, step-ups,
chest press, etc. The circuit was continuous & lasted for 40
minutes, consisting of 1 minute exercise stations (40 exercise
stations). Exercise intensity monitored through a combination of
pulse monitoring and RPE (midpoint & end of circuit). Participants
encouraged to exercise at an RPE of 11-15 dependent on ability.
CV Cool Down, Stretching & Balance (10 minutes + 10 minutes)
Easy 10 minute walking cool down with stationary activities for
those less mobile, followed by functional mobility & static
stretching exercises to promote muscle lengthening & avoid
adaptive shortening, especially around the chest & shoulders.
Static & dynamic balance exercise challenges also incorporated.
Key: 
6MWT = 6-minute walk test
HR = heart rate
*p<0.05
Table 1. Health & Functional Data for Phase IV Participants in 
2018 & 2019 
Discussion
Phase IV exercise training seems to offer the opportunity for
participants in their mid-70s to improve functional capacity as
measured by distance achieved in 6MWT & at a lower physiological
cost (reduced 6MWT Terminal HR in 2019), even though they were 1-
year older. It also helps to maintain a healthy BP, although other risk
factors related to obesity metrics need further attention.




Difference Paired Sample 
T-test P value
BMI (kg/m2) 26.20 ± 2.99 26.41 ± 2.98 + 0.21 0.394
WC (cm) 92.79 ± 9.94 93.96 ± 10.79 + 1.17 0.088
SBP (mmHg) 135.64 ± 16.91 131.68 ± 17.43 - 3.96 0.276
DBP (mmHg) 75.80 ± 10.02 73.20 ± 10.95 - 2.60 0.209
RHR (bpm) 63.32 ± 9.20 63.92 ± 8.05 + 0.60 0.688
6MWD (m) 492.16 ± 79.97 509.20 ± 90.85 + 17.04 0.037*
6MWT Terminal HR (bpm) 93.17 ± 24.54 89.96 ± 14.41 - 3.21 0.569
